Keren Landman is a Senior Health and Science Reporter. She focuses on health and wellness, exploring various aspects of well-being and public health issues. Keren's work has been featured in prominent publications such as RealClearMarkets, RealClearHealth, Environmental Health News, Vox, and The Atlantic.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Not enough data
Keren Landman's coverage predominantly focuses on health, healthcare, and pharmaceuticals. Her articles often cite data and government announcements, indicating a reliance on factual information and official statements. She would likely be interested in pitches from experts who can provide data-backed insights into public health issues or developments in the medical field.
Given her focus on specific health challenges faced by different demographic groups, Keren may respond well to sources with expertise in women's health or those working directly with affected communities. Pitches featuring innovative approaches to addressing public health concerns or highlighting underreported issues could also capture her attention.
While there is no specified geographic focus for Keren's coverage, she appears to cover topics that are relevant at a national level within the United States.
This information evolves through artificial intelligence and human feedback. Improve this profile .
“I'm actually surprised it didn't happen sooner.” When gunfire pelted the Atlanta-based headquarters of the CDC yesterday, hundreds of employees were inside the campus's buildings.
Information on subjects other than vaccines is largely reliable—for now.
Agency workers say that information on subjects other than vaccines is largely reliable—for now.
There's a special frisson to period changes in your mid-forties. Every deviation from your usual pattern can feel like a harbinger of the menopause transition, also known as perimenopause.
Doctors say diagnosis is usually clinical and doesn’t rely on a blood test, with symptoms often starting in the mid-40s
